DrugPatentWatch Database Preview

Par Form Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PAR FORM, and what generic and branded alternatives to PAR FORM drugs are available?

PAR FORM has five approved drugs.

There is one tentative approval on PAR FORM drugs.

Summary for Par Form

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5
Patent Litigation for Par Form:	See patent lawsuits for Par Form

Drugs and US Patents for Par Form

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Form	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	200908-002	Jul 10, 2012	AB	RX	No	No
Par Form	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	TABLET;ORAL	203836-001	Aug 19, 2016	AB	RX	No	No
Par Form	MAFENIDE ACETATE	mafenide acetate	FOR SOLUTION;TOPICAL	201511-001	Feb 12, 2013	AT	RX	No	No
Par Form	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	200908-001	Jul 10, 2012	AB	RX	No	No
Par Form	ZOLPIDEM TARTRATE	zolpidem tartrate	TABLET;SUBLINGUAL	201509-002	Aug 1, 2016	AB	RX	No	No
Par Form	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	TABLET;ORAL	203836-002	Aug 19, 2016	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Par Form
• Par Pharm
• Par Pharm Inc
• Par Sterile Products